In the United States, FDA approved four-dose Mounjaro and Zepbound KwikPens on January 20, 2026, while single-dose Mounjaro and Zepbound pens and vials also remain in use
Asthma and Diabetes Mellitus Both asthma and type 2 diabetes (T2D) are common conditions around the world, affecting hundreds of millions of people [15, 16], with obesity levels also increasing worldwide in similar if not higher numbers, especially in developing countries as they adopt a more western lifestyle [17]
Springer, pp 635722 Marcus JB (2013) In: Marcus JB (ed) Culinary nutrition
We talk through any history of cancer, pituitary disease, or diabetes first, since the protocol isn't appropriate with active or recent cancer or with pituitary disease, and there's no safety data in pregnancy or breastfeeding